{"count": 11, "results": [{"_id": "39375240", "pmid": 39375240, "title": "Therapeutic Effects of Metformin on Central Nervous System Diseases: A Focus on Protection of Neurovascular Unit.", "journal": "Pharm Res", "authors": ["Cai C", "Gu C", "Meng C", "He S", "Thashi L", "Deji D", "Zheng Z", "Qiu Q"], "date": "2024-10-07T00:00:00Z", "doi": "10.1007/s11095-024-03777-0", "meta_date_publication": "2024 Oct 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50267.047, "text_hl": "Therapeutic Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@Central Nervous System Diseases@@@: A Focus on Protection of Neurovascular Unit.", "citations": {"NLM": "Cai C, Gu C, Meng C, He S, Thashi L, Deji D, Zheng Z, Qiu Q. Therapeutic Effects of Metformin on Central Nervous System Diseases: A Focus on Protection of Neurovascular Unit. Pharm Res. 2024 Oct 7;():. PMID: 39375240", "BibTeX": "@article{39375240, title={Therapeutic Effects of Metformin on Central Nervous System Diseases: A Focus on Protection of Neurovascular Unit.}, author={Cai C and Gu C and Meng C and He S and Thashi L and Deji D and Zheng Z and Qiu Q}, journal={Pharm Res}}"}}, {"_id": "31998447", "pmid": 31998447, "pmcid": "PMC6969994", "title": "Metformin Promotes Axon Regeneration after Spinal Cord Injury through Inhibiting Oxidative Stress and Stabilizing Microtubule", "journal": "Oxid Med Cell Longev", "authors": ["Wang H", "Zheng Z", "Han W", "Yuan Y", "Li Y", "Zhou K", "Wang Q", "Xie L", "Xu K", "Zhang H", "Xu H", "Wu Y", "Xiao J"], "date": "2020-01-06T00:00:00Z", "doi": "10.1155/2020/9741369", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "9741369", "score": 50257.008, "text_hl": "Thus, seeking for valid drugs that are beneficial to promoting axonal regrowth and elongation after @DISEASE_Spinal_Cord_Injuries @DISEASE_MESH:D013119 @@@SCI@@@ has gained wide attention. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@-lowering agent, has been demonstrated to play roles in various @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@central nervous system (CNS) disorders@@@. ", "citations": {"NLM": "Wang H, Zheng Z, Han W, Yuan Y, Li Y, Zhou K, Wang Q, Xie L, Xu K, Zhang H, Xu H, Wu Y, Xiao J. Metformin Promotes Axon Regeneration after Spinal Cord Injury through Inhibiting Oxidative Stress and Stabilizing Microtubule Oxid Med Cell Longev. 2020;2020():9741369. PMID: 31998447", "BibTeX": "@article{31998447, title={Metformin Promotes Axon Regeneration after Spinal Cord Injury through Inhibiting Oxidative Stress and Stabilizing Microtubule}, author={Wang H and Zheng Z and Han W and Yuan Y and Li Y and Zhou K and Wang Q and Xie L and Xu K and Zhang H and Xu H and Wu Y and Xiao J}, journal={Oxid Med Cell Longev}, volume={2020}, pages={9741369}}"}}, {"_id": "39225830", "pmid": 39225830, "title": "Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Ashayeri Ahmadabad H", "Mohammadi Panah S", "Ghasemnejad-Berenji H", "Ghojavand S", "Ghasemnejad-Berenji M", "Khezri MR"], "date": "2024-09-03T00:00:00Z", "doi": "10.1007/s00210-024-03358-3", "meta_date_publication": "2024 Sep 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.926, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and the @GENE_PIK3CD @GENE_5293 @@@PI3K@@@/@GENE_AKT1 @GENE_207 @@@AKT@@@ signaling pathway: implications for @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@, @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@cardiovascular, and central nervous system diseases@@@.", "citations": {"NLM": "Ashayeri Ahmadabad H, Mohammadi Panah S, Ghasemnejad-Berenji H, Ghojavand S, Ghasemnejad-Berenji M, Khezri MR. Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases. Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep 3;():. PMID: 39225830", "BibTeX": "@article{39225830, title={Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.}, author={Ashayeri Ahmadabad H and Mohammadi Panah S and Ghasemnejad-Berenji H and Ghojavand S and Ghasemnejad-Berenji M and Khezri MR}, journal={Naunyn Schmiedebergs Arch Pharmacol}}"}}, {"_id": "33716063", "pmid": 33716063, "title": "Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.", "journal": "Life Sci", "authors": ["Sharma S", "Nozohouri S", "Vaidya B", "Abbruscato T"], "date": "2021-06-01T00:00:00Z", "doi": "10.1016/j.lfs.2021.119343", "meta_date_publication": "2021 Jun 1", "meta_volume": "274", "meta_issue": "", "meta_pages": "119343", "score": 50254.69, "text_hl": "Considering @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s beneficial preclinical actions on various disorders, and the drug's role in alleviating severity of these conditions through involvement in commonly characterized cellular pathways, we discuss the potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a suitable drug candidate for repurposing in @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@CNS disorders@@@.", "citations": {"NLM": "Sharma S, Nozohouri S, Vaidya B, Abbruscato T. Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke. Life Sci. 2021 Jun 1;274():119343. PMID: 33716063", "BibTeX": "@article{33716063, title={Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.}, author={Sharma S and Nozohouri S and Vaidya B and Abbruscato T}, journal={Life Sci}, volume={274}, pages={119343}}"}}, {"_id": "35370693", "pmid": 35370693, "pmcid": "PMC8969021", "title": "Metformin Inhibits NLR Family Pyrin Domain Containing 3 (NLRP)-Relevant Neuroinflammation via an Adenosine-5'-Monophosphate-Activated Protein Kinase (AMPK)-Dependent Pathway to Alleviate Early Brain Injury After Subarachnoid Hemorrhage in Mice", "journal": "Front Pharmacol", "authors": ["Jin L", "Jin F", "Guo S", "Liu W", "Wei B", "Fan H", "Li G", "Zhang X", "Su S", "Li R", "Fang D", "Duan C", "Li X"], "date": "2022-03-17T00:00:00Z", "doi": "10.3389/fphar.2022.796616", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "796616", "score": 50245.16, "text_hl": "Previous studies have shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exerts anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ effects and promotes functional recovery in various @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@central nervous system diseases@@@. ", "citations": {"NLM": "Jin L, Jin F, Guo S, Liu W, Wei B, Fan H, Li G, Zhang X, Su S, Li R, Fang D, Duan C, Li X. Metformin Inhibits NLR Family Pyrin Domain Containing 3 (NLRP)-Relevant Neuroinflammation via an Adenosine-5'-Monophosphate-Activated Protein Kinase (AMPK)-Dependent Pathway to Alleviate Early Brain Injury After Subarachnoid Hemorrhage in Mice Front Pharmacol. 2022;13():796616. PMID: 35370693", "BibTeX": "@article{35370693, title={Metformin Inhibits NLR Family Pyrin Domain Containing 3 (NLRP)-Relevant Neuroinflammation via an Adenosine-5'-Monophosphate-Activated Protein Kinase (AMPK)-Dependent Pathway to Alleviate Early Brain Injury After Subarachnoid Hemorrhage in Mice}, author={Jin L and Jin F and Guo S and Liu W and Wei B and Fan H and Li G and Zhang X and Su S and Li R and Fang D and Duan C and Li X}, journal={Front Pharmacol}, volume={13}, pages={796616}}"}}, {"_id": "37236132", "pmid": 37236132, "title": "Metformin promotes Schwann cell remyelination, preserves neural tissue and improves functional recovery after spinal cord injury.", "journal": "Neuropeptides", "authors": ["Huang Z", "Lin J", "Jiang H", "Lin W", "Huang Z", "Chen J", "Xiao W", "Lin Q", "Wang J", "Wen S", "Zhu Q", "Liu J"], "date": "2023-05-19T00:00:00Z", "doi": "10.1016/j.npep.2023.102348", "meta_date_publication": "2023 May 19", "meta_volume": "100", "meta_issue": "", "meta_pages": "102348", "score": 50244.566, "text_hl": "Considering this, @DISEASE_Spinal_Cord_Injuries @DISEASE_MESH:D013119 @@@SCI@@@ treatment and pathology study are urgently needed. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, a widely used hypoglycemic drug, has been indicated for its important role in @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@central nervous system diseases@@@. ", "citations": {"NLM": "Huang Z, Lin J, Jiang H, Lin W, Huang Z, Chen J, Xiao W, Lin Q, Wang J, Wen S, Zhu Q, Liu J. Metformin promotes Schwann cell remyelination, preserves neural tissue and improves functional recovery after spinal cord injury. Neuropeptides. 2023 May 19;100():102348. PMID: 37236132", "BibTeX": "@article{37236132, title={Metformin promotes Schwann cell remyelination, preserves neural tissue and improves functional recovery after spinal cord injury.}, author={Huang Z and Lin J and Jiang H and Lin W and Huang Z and Chen J and Xiao W and Lin Q and Wang J and Wen S and Zhu Q and Liu J}, journal={Neuropeptides}, volume={100}, pages={102348}}"}}, {"_id": "35115909", "pmid": 35115909, "pmcid": "PMC8806158", "title": "Metformin Alleviates Neuroinflammation Following Intracerebral Hemorrhage in Mice by Regulating Microglia/Macrophage Phenotype in a Gut Microbiota-Dependent Manner", "journal": "Front Cell Neurosci", "authors": ["Yu X", "Fu X", "Wu X", "Tang W", "Xu L", "Hu L", "Xu C", "Zhou H", "Zhou G", "Li J", "Cao S", "Liu J", "Yan F", "Wang L", "Liu F", "Chen G"], "date": "2022-01-18T00:00:00Z", "doi": "10.3389/fncel.2021.789471", "meta_date_publication": "2021", "meta_volume": "15", "meta_issue": "", "meta_pages": "789471", "score": 50241.59, "text_hl": "The anti-@DISEASE_Neuroinflammatory_Diseases @DISEASE_MESH:D000090862 @@@neuroinflammatory@@@ effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@Met@@@) have been reported in many @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@central nervous system (CNS) diseases@@@. ", "citations": {"NLM": "Yu X, Fu X, Wu X, Tang W, Xu L, Hu L, Xu C, Zhou H, Zhou G, Li J, Cao S, Liu J, Yan F, Wang L, Liu F, Chen G. Metformin Alleviates Neuroinflammation Following Intracerebral Hemorrhage in Mice by Regulating Microglia/Macrophage Phenotype in a Gut Microbiota-Dependent Manner Front Cell Neurosci. 2021;15():789471. PMID: 35115909", "BibTeX": "@article{35115909, title={Metformin Alleviates Neuroinflammation Following Intracerebral Hemorrhage in Mice by Regulating Microglia/Macrophage Phenotype in a Gut Microbiota-Dependent Manner}, author={Yu X and Fu X and Wu X and Tang W and Xu L and Hu L and Xu C and Zhou H and Zhou G and Li J and Cao S and Liu J and Yan F and Wang L and Liu F and Chen G}, journal={Front Cell Neurosci}, volume={15}, pages={789471}}"}}, {"_id": "40421051", "pmid": 40421051, "title": "Ameliorative potential of metformin in LPS and glutamate-induced neurotoxicity in N2a cell-line.", "journal": "Cytotechnology", "authors": ["Deepshikha", "Shekhar N", "Tyagi S", "Thakur AK"], "date": "2025-06-01T00:00:00Z", "doi": "10.1007/s10616-025-00777-9", "meta_date_publication": "2025 Jun", "meta_volume": "77", "meta_issue": "3", "meta_pages": "107", "score": 50241.17, "text_hl": "These findings imply that due to the anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@, diminishing reactive oxidative species, and antioxidant properties of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, it can be considered a therapeutic drug candidate for treating and managing @DISEASE_Neurologic_Manifestations @DISEASE_MESH:D009461 @@@neurological disorders@@@ and @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@CNS complications@@@ associated with @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic abnormalities@@@. ", "citations": {"NLM": "Deepshikha, Shekhar N, Tyagi S, Thakur AK. Ameliorative potential of metformin in LPS and glutamate-induced neurotoxicity in N2a cell-line. Cytotechnology. 2025 Jun;77(3):107. PMID: 40421051", "BibTeX": "@article{40421051, title={Ameliorative potential of metformin in LPS and glutamate-induced neurotoxicity in N2a cell-line.}, author={Deepshikha and Shekhar N and Tyagi S and Thakur AK}, journal={Cytotechnology}, volume={77}, number={3}, pages={107}}"}}, {"_id": "37119382", "pmid": 37119382, "title": "Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway.", "journal": "Metab Brain Dis", "authors": ["Fan P", "Lu Y", "Wei H", "Wang K", "Jia P", "Zhang Y", "Zhang Y", "Wang T", "Yang L", "Zhao J", "Zhang S", "Lu H", "Chen X", "Liu Y", "Zhang P"], "date": "2023-04-29T00:00:00Z", "doi": "10.1007/s11011-023-01218-2", "meta_date_publication": "2023 Apr 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50239.727, "text_hl": "Our findings suggested that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could reduce @CHEMICAL_Sevoflurane @CHEMICAL_MESH:D000077149 @@@sevoflurane@@@-induced @DISEASE_Urinary_Bladder_Neurogenic @DISEASE_MESH:D001750 @@@neurogenesis damage@@@ and @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@neurocognitive defects@@@ in the developing @SPECIES_10116 @@@rat@@@ brain by influencing the @GENE_NFE2L2 @GENE_83619 @@@Nrf2@@@/@GENE_G6PD @GENE_24377 @@@G6PD@@@ signaling pathways.", "citations": {"NLM": "Fan P, Lu Y, Wei H, Wang K, Jia P, Zhang Y, Zhang Y, Wang T, Yang L, Zhao J, Zhang S, Lu H, Chen X, Liu Y, Zhang P. Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway. Metab Brain Dis. 2023 Apr 29;():. PMID: 37119382", "BibTeX": "@article{37119382, title={Metformin attenuates sevoflurane-induced neurogenesis damage and cognitive impairment: involvement of the Nrf2/G6PD pathway.}, author={Fan P and Lu Y and Wei H and Wang K and Jia P and Zhang Y and Zhang Y and Wang T and Yang L and Zhao J and Zhang S and Lu H and Chen X and Liu Y and Zhang P}, journal={Metab Brain Dis}}"}}, {"_id": "29512848", "pmid": 29512848, "title": "Metformin ameliorates the age-related changes of d-galactose administration in ovariectomized mice.", "journal": "Fundam Clin Pharmacol", "authors": ["Fatemi I", "Heydari S", "Kaeidi A", "Shamsizadeh A", "Hakimizadeh E", "Khaluoi A", "Allahtavakoli M"], "date": "2018-08-01T00:00:00Z", "doi": "10.1111/fcp.12364", "meta_date_publication": "2018 Aug", "meta_volume": "32", "meta_issue": "4", "meta_pages": "392-399", "score": 50046.773, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) has been shown to have pleiotropic effects such as neuroprotective, antioxidant, and anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ properties making that a potential candidate for the treatment of @<m>DISEASE_Central_Nervous_System_Diseases</m> @DISEASE_MESH:D002493 @@@central nervous system (CNS) disorders@@@. ", "citations": {"NLM": "Fatemi I, Heydari S, Kaeidi A, Shamsizadeh A, Hakimizadeh E, Khaluoi A, Allahtavakoli M. Metformin ameliorates the age-related changes of d-galactose administration in ovariectomized mice. Fundam Clin Pharmacol. 2018 Aug;32(4):392-399. PMID: 29512848", "BibTeX": "@article{29512848, title={Metformin ameliorates the age-related changes of d-galactose administration in ovariectomized mice.}, author={Fatemi I and Heydari S and Kaeidi A and Shamsizadeh A and Hakimizadeh E and Khaluoi A and Allahtavakoli M}, journal={Fundam Clin Pharmacol}, volume={32}, number={4}, pages={392-399}}"}}]}